CTLA4 and neoplasm: Currently, there are at least four types of immunotherapy strategies: immune checkpoint inhibitors (ICIs), such as programmed cell death protein 1 (PD-1) and Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4), chimeric antigen receptor T cell therapy, tumour vaccines, and lastly, peripatetic immunotherapy.